What are the current diagnostic levels of Hemoglobin A1c (HbA1c)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Diagnostic Levels of HbA1c

An HbA1c level of ≥6.5% (≥48 mmol/mol) is diagnostic for diabetes, while levels of 5.7% to 6.4% (39-46 mmol/mol) indicate prediabetes or high risk for developing diabetes. 1, 2

Diabetes Diagnosis

  • The diagnostic threshold is HbA1c ≥6.5% (≥48 mmol/mol) using an NGSP-certified method performed in an accredited laboratory. 3, 1, 2

  • Confirmation is required through either a repeat HbA1c test on a different sample or a glucose-based test (fasting glucose or OGTT), unless the patient presents with unequivocal hyperglycemia and classic symptoms. 1, 2

  • For borderline cases (HbA1c 6.5-6.9%), confirm with a fasting blood glucose level of ≥126 mg/dL (≥7.0 mmol/L) to account for racial/ethnic variations and measurement variability. 3

Prediabetes Diagnosis

  • HbA1c levels of 5.7% to 6.4% (39-46 mmol/mol) identify individuals at high risk for developing diabetes who would benefit from prevention interventions. 3, 1, 2

  • This range was established by the American Diabetes Association, though some international guidelines use 6.0-6.4% as the prediabetes threshold. 3

Critical Testing Requirements

  • Only use NGSP-certified methods standardized to the Diabetes Control and Complications Trial (DCCT) assay. 3, 2

  • Testing must be performed in CLIA-certified laboratories of moderate complexity or higher. 2

  • Point-of-care HbA1c devices should not be used for diagnosis unless specifically FDA-approved for diagnostic purposes and performed in appropriately certified laboratories. 2

Important Caveats and Limitations

HbA1c cannot be used for diagnosis in specific conditions:

  • Hemoglobinopathies (sickle cell disease, thalassemia) that interfere with measurement. 2
  • Pregnancy or gestational diabetes screening. 3, 2
  • Conditions with increased red blood cell turnover (hemolytic anemia, recent blood loss, iron deficiency anemia). 3, 2
  • Chronic kidney disease, which may alter HbA1c measurement. 3

Measurement considerations:

  • Sequential HbA1c values within 0.5% do not statistically differ unless the assay coefficient of variation is <3% (ideally <2%). 3
  • Marked discordance between HbA1c and plasma glucose should raise suspicion for assay interference and prompt use of glucose-based criteria instead. 2
  • HbA1c at 6.5% identifies only about 30% of diabetes cases that would be diagnosed collectively using HbA1c, fasting glucose, or 2-hour glucose testing, meaning it has lower sensitivity than glucose-based criteria. 2

Historical Context

  • Prior to 2009-2010, HbA1c was not recommended for diagnosis. The 2003 guidelines explicitly stated HbA1c should not be used diagnostically due to lack of standardization and difficulty assigning appropriate cutpoints. 3

  • The shift to using HbA1c for diagnosis became possible through improved assay standardization via the NGSP and new data demonstrating associations between HbA1c concentrations and risk for retinopathy. 3

References

Guideline

Diagnosis and Management of Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.